William A. Haseltine, Contributor

Author's posts

The Dramatic Cost Of The Covid-19 Pandemic: A Historical Drop In Life Expectancy

New data from the CDC shows that U.S. life expectancy dropped by a total of 2.7 years between 2019 and 2021 to 76.1 years, the lowest number since 1996.

As Protection From Current Covid-19 Monoclonal Antibody Treatments Fades, The Discovery Of A New Class Of Antibodies Brings Hope

New classes of antibodies may be one of our best tools to overcome new immune evasive variants.

Reimagining Alzheimer’s (Part 4): Cautious Optimism For A New Alzheimer’s Disease Treatment

Cautious optimism about the use of a new anti-amyloid fibril antibody for the treatment of early-stage Alzheimer’s.

Broadly Neutralizing SARS-CoV-2 Antibodies From Immunized Macaque Monkeys

Monoclonal antibodies derived from macaque monkeys may be a new tool to fight against moderate to severe Covid-19.

Introducing A “Naked” Self-Amplifying RNA Vaccine Candidate

Researchers have developed a “naked” self-amplifying RNA vaccine optimized for injection into the skin, rather than the muscle.

How Enhanced Ventilation And Air Filtration Can Fight Covid-19

Improving air management can help fight Covid-19

CAR T Therapy For Drug Resistant Multiple Myeloma

Patients with drug-resistant multiple myeloma find early success with a new CAR T therapy, a recent study finds

Reimagining Alzheimer’s (Part 3): The APOE Story In Alzheimer’s And Other Diseases

In part 3 of my series on Alzheimer’s, I explore the different variants of APOE— the primary gene associated with Alzheimer’s disease.

Children Experiencing Respiratory Trouble Post-Covid-19 Improve With The Use Of An Inhaler And Exercise Regimen

The most common of these symptoms is pediatric dyspnea, otherwise known as shortness of breath or difficulty breathing.

Progress In The Search To Reverse Age-Related Vision Loss

Thanks to new techniques in regenerative medicine we are now closer to a future where your own cells can be used to restore the sense of vision.